Advances in the next-generation whole-exome sequencing have identified multiple de novo missense mutations in GNAO1—the gene encoding Gαo—as the cause of rare yet severe neurological syndromes ranging from developmental delay with various movement disorders to early onset developmental and epileptic encephalopathy (DEE) [14,15,16]. This evidence concerns the gene GNAO1 and movement disorder.